Noncoding RNAs Are Promising Therapeutic Targets for Diabetic Retinopathy: An Updated Review (2017-2022)

Overview

Journal Biomolecules

Publisher MDPI

Specialties Biochemistry
Molecular Biology

Date 2022 Dec 23

PMID 36551201

Authors

Mengchen Wang

Qiaoyu Li

Meiqi Jin

Zhen Wang

Xuelian Zhang

Xiaobo Sun

Yun Luo

Affiliations

Soon will be listed here.

Abstract

Diabetic retinopathy (DR) is the most common complication of diabetes. It is also the main cause of blindness caused by multicellular damage involving retinal endothelial cells, ganglial cells, and pigment epithelial cells in adults worldwide. Currently available drugs for DR do not meet the clinical needs; thus, new therapeutic targets are warranted. Noncoding RNAs (ncRNAs), a new type of biomarkers, have attracted increased attention in recent years owing to their crucial role in the occurrence and development of DR. NcRNAs mainly include microRNAs, long noncoding RNAs, and circular RNAs, all of which regulate gene and protein expression, as well as multiple biological processes in DR. NcRNAs, can regulate the damage caused by various retinal cells; abnormal changes in the aqueous humor, exosomes, blood, tears, and the formation of new blood vessels. This study reviews the different sources of the three ncRNAs-microRNAs, long noncoding RNAs, and circular RNAs-involved in the pathogenesis of DR and the related drug development progress. Overall, this review improves our understanding of the role of ncRNAs in various retinal cells and offers therapeutic directions and targets for DR treatment.

Citing Articles

Deciphering the role of exosomal derived regulatory noncoding RNAs as potential biomarkers for diabetic retinopathy: a systematic review.

Nandalal S, Venkatesan H, Haridoss M, Ramachandran K, Lenin R Int J Retina Vitreous. 2024; 10(1):93.

PMID: 39695892 PMC: 11657862. DOI: 10.1186/s40942-024-00615-8.

Identification of genes related to fatty acid metabolism in type 2 diabetes mellitus.

Yang J, Zhou Y, Zhang J, Zheng Y, He J Biochem Biophys Rep. 2024; 40:101849.

PMID: 39498440 PMC: 11532806. DOI: 10.1016/j.bbrep.2024.101849.

Classical and Innovative Evidence for Therapeutic Strategies in Retinal Dysfunctions.

Caruso L, Fields M, Rimondi E, Zauli G, Longo G, Marcuzzi A Int J Mol Sci. 2024; 25(4).

PMID: 38396799 PMC: 10889839. DOI: 10.3390/ijms25042124.

Exosomal noncoding RNA: A potential therapy for retinal vascular diseases.

Heo J, Ryu J Mol Ther Nucleic Acids. 2024; 35(1):102128.

PMID: 38356865 PMC: 10865410. DOI: 10.1016/j.omtn.2024.102128.

Relationship between Biochemical Pathways and Non-Coding RNAs Involved in the Progression of Diabetic Retinopathy.

Mrowicka M, Mrowicki J, Majsterek I J Clin Med. 2024; 13(1).

PMID: 38202299 PMC: 10779474. DOI: 10.3390/jcm13010292.

References

Liu H, Stepicheva N, Ghosh S, Shang P, Chowdhury O, Daley R . Reducing Akt2 in retinal pigment epithelial cells causes a compensatory increase in Akt1 and attenuates diabetic retinopathy. Nat Commun. 2022; 13(1):6045. PMC: 9561713. DOI: 10.1038/s41467-022-33773-0. View

Zhu K, Hu X, Chen H, Li F, Yin N, Liu A . Downregulation of circRNA DMNT3B contributes to diabetic retinal vascular dysfunction through targeting miR-20b-5p and BAMBI. EBioMedicine. 2019; 49:341-353. PMC: 6945224. DOI: 10.1016/j.ebiom.2019.10.004. View

Chen L, Heikkinen L, Wang C, Yang Y, Sun H, Wong G . Trends in the development of miRNA bioinformatics tools. Brief Bioinform. 2018; 20(5):1836-1852. PMC: 7414524. DOI: 10.1093/bib/bby054. View

Zhang X, Shi E, Yang L, Fu W, Hu F, Zhou X . LncRNA AK077216 is downregulated in diabetic retinopathy and inhibited the apoptosis of retinal pigment epithelial cells by downregulating miR-383. Endocr J. 2019; 66(11):1011-1016. DOI: 10.1507/endocrj.EJ19-0080. View

Monteiro J, Santos F, Rocha A, Castro-de-Sousa J, Queiroz J, Passarinha L . Vitreous humor in the pathologic scope: insights from proteomic approaches. Proteomics Clin Appl. 2014; 9(1-2):187-202. DOI: 10.1002/prca.201400133. View

Liu J, Hou Y, Lin L, Yu N, Zhang Y . MicroRNA-5195-3p alleviates high glucose‑induced injury in human ARPE-19 cells by targeting GMFB. PLoS One. 2021; 16(11):e0260071. PMC: 8601420. DOI: 10.1371/journal.pone.0260071. View

Thomas A, Biswas S, Feng B, Chen S, Gonder J, Chakrabarti S . lncRNA H19 prevents endothelial-mesenchymal transition in diabetic retinopathy. Diabetologia. 2019; 62(3):517-530. DOI: 10.1007/s00125-018-4797-6. View

Cao M, Zhang L, Wang J, Zeng H, Peng Y, Zou J . Identifying circRNA-associated-ceRNA networks in retinal neovascularization in mice. Int J Med Sci. 2019; 16(10):1356-1365. PMC: 6818188. DOI: 10.7150/ijms.35149. View

Platania C, Maisto R, Trotta M, DAmico M, Rossi S, Gesualdo C . Retinal and circulating miRNA expression patterns in diabetic retinopathy: An in silico and in vivo approach. Br J Pharmacol. 2019; 176(13):2179-2194. PMC: 6555853. DOI: 10.1111/bph.14665. View

10.

Dong N, Xu B, Shi H . Long noncoding RNA MALAT1 acts as a competing endogenous RNA to regulate Amadori-glycated albumin-induced MCP-1 expression in retinal microglia by a microRNA-124-dependent mechanism. Inflamm Res. 2018; 67(11-12):913-925. DOI: 10.1007/s00011-018-1184-1. View

11.

Caporarello N, DAngeli F, Cambria M, Candido S, Giallongo C, Salmeri M . Pericytes in Microvessels: From "Mural" Function to Brain and Retina Regeneration. Int J Mol Sci. 2019; 20(24). PMC: 6940987. DOI: 10.3390/ijms20246351. View

12.

Alexandru N, Procopciuc A, Vilcu A, Comarita I, Bdil E, Georgescu A . Extracellular vesicles-incorporated microRNA signature as biomarker and diagnosis of prediabetes state and its complications. Rev Endocr Metab Disord. 2021; 23(3):309-332. DOI: 10.1007/s11154-021-09664-y. View

13.

Li W, Jin L, Cui Y, Nie A, Xie N, Liang G . Bone marrow mesenchymal stem cells-induced exosomal microRNA-486-3p protects against diabetic retinopathy through TLR4/NF-κB axis repression. J Endocrinol Invest. 2020; 44(6):1193-1207. DOI: 10.1007/s40618-020-01405-3. View

14.

Dong Y, Wan G, Peng G, Yan P, Qian C, Li F . Long non-coding RNA XIST regulates hyperglycemia-associated apoptosis and migration in human retinal pigment epithelial cells. Biomed Pharmacother. 2020; 125:109959. DOI: 10.1016/j.biopha.2020.109959. View

15.

Zhou L, Li F, Wang S . Circ-ITCH restrains the expression of MMP-2, MMP-9 and TNF-α in diabetic retinopathy by inhibiting miR-22. Exp Mol Pathol. 2020; 118:104594. DOI: 10.1016/j.yexmp.2020.104594. View

16.

Liang G, Luo Y, Wei R, Yin J, Qin Z, Lu L . CircZNF532 knockdown protects retinal pigment epithelial cells against high glucose-induced apoptosis and pyroptosis by regulating the miR-20b-5p/STAT3 axis. J Diabetes Investig. 2021; 13(5):781-795. PMC: 9077727. DOI: 10.1111/jdi.13722. View

17.

Zhang R, Ma X, Jiang L, Xia W, Li H, Zhao N . Decreased lncRNA SNHG16 Accelerates Oxidative Stress Induced Pathological Angiogenesis in Human Retinal Microvascular Endothelial Cells by Regulating miR-195/mfn2 Axis. Curr Pharm Des. 2021; 27(27):3047-3060. DOI: 10.2174/1381612827666210202141541. View

18.

Liu H, Cao N, Li X, Qian W, Chen X . Serum microRNA-211 as a biomarker for diabetic retinopathy via modulating Sirtuin 1. Biochem Biophys Res Commun. 2018; 505(4):1236-1243. DOI: 10.1016/j.bbrc.2018.10.052. View

19.

Nawaz I, Rezzola S, Cancarini A, Russo A, Costagliola C, Semeraro F . Human vitreous in proliferative diabetic retinopathy: Characterization and translational implications. Prog Retin Eye Res. 2019; 72:100756. DOI: 10.1016/j.preteyeres.2019.03.002. View

20.

Tong P, Peng Q, Gu L, Xie W, Li W . LncRNA-MEG3 alleviates high glucose induced inflammation and apoptosis of retina epithelial cells via regulating miR-34a/SIRT1 axis. Exp Mol Pathol. 2018; 107:102-109. DOI: 10.1016/j.yexmp.2018.12.003. View